| Name | Guanabenz |
|---|
| Description | (E)-Guanabenz ((E)-Wy-8678) is an orally active central α2-adrenoceptor agonist. (E)-Guanabenz has antihypertensive activity, acts via stimulating central α2-adrenoceptors, and reducing net sympathetic outflow into the periphery. (E)-Guanabenz also directly binds to and inhibits GADD34, and has neuroprotective activity. (E)-Guanabenz can be used for researching hypertension and Parkinson disease[1][2]. |
|---|---|
| Related Catalog | |
| Target |
α2-adrenoceptor, GADD34[1][2] |
| References |
| Molecular Formula | C8H8Cl2N4 |
|---|---|
| Molecular Weight | 231.08200 |
| Exact Mass | 230.01300 |
| PSA | 76.76000 |
| LogP | 3.00130 |